Nevertheless, and to further address whether the fulvestrant‐induced growth arrest contributes to the activation of inflammatory signaling, we deleted the CSK kinase in MCF7 cells using CRISPR, as this mutation has been shown to confer estrogen signaling‐independent growth on ER+ BC cells [40, 41]. The gene discussed is ESR1; the disease is breast cancer.